Position in NBIX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$9,943
+$2,830 QoQ
Shares Held
59
+9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#684
of 768 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sachetta, LLC holds $71,971 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
36 | $19,505 | |
| 2 | VTRS |
Viatris Inc
|
1,190 | $18,896 | |
| 3 | ALKS |
Alkermes plc.
|
220 | $11,526 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
59 | $9,943 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
283 | $6,964 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
145 | $5,027 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1 | $110 |
All Filings in NBIX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,943 | 59 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $7,113 | 54 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $7,658 | 54 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $7,580 | 54 | Shares | Defined | 2025-10-24 | |
| 2025-06-30 | $6,787 | 54 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $1,327 | 12 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $4,914 | 36 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $1,382 | 12 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $1,652 | 12 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $1,655 | 12 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,581 | 12 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||